Antithrombotic Therapy After LAAO: Changes in Care

Speaker:

Abhijeet Dhoble, MD, FACC - Director, Structural Heart Interventions, University of Texas Health Science Center, Houston

Moderator:

Julie Mobayed, MPH, BSN, RN, CPHQ, AACC - Director, LAAO Registry Program Manager, National Quality Campaigns, American College of Cardiology

Description:
This session will discuss the changes in Antithrombotic therapy after patients receive an LAAO device including: DAPT Therapy, Changing Strategies and Bleeding Events. 

Learning Objectives:

• Recognize at least one change in antithrombotic medications, dosing, and duration for LAAO patients.
• Identify strategies for prescription writing, patient communications, follow-up monitoring, and provider communications.
• Recognize the potential for bleeding events with antithrombotic therapy changes.